Project Grant HT94252310438
Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Louisiana, USA
Similar Awards
- The Defense Health Agency awarded Louisiana State University Health Sciences Center-New Orleans a $277,340 Project Grant under the Military Medical Research and Development program to conduct research targeting the host immune response in COVID-19 via adenosine-mediated immunomodulation. The grant supports LSU Health Sciences Center-New Orleans' research efforts from January 2021 through January 2024. The Military Medical Research and Development program aims to transform health care for service...
- The Louisiana State University Health Sciences Center-New Orleans (LSU Health Sciences Center New Orleans) will receive $723,066 under a three-year Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The grant will fund research into developing an intraosseous antibiotic delivery system for point-of-care wound prophylaxis....
- This $221,997 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Louisiana State University to develop a MIGRASOME-BASED DUAL-COLOR PATH TRACER OF DISSEMINATED TUMOR CELLS FOR STUDYING EARLY-STAGE BONE METASTASES OF PROSTATE CANCER CELLS. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions...
- This $377,932 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Louisiana State University Health Sciences Center New Orleans to develop innovative techniques for dispersing bacterial biofilms on bones and medical hardware. The research aims to improve the treatment of bone fractures and infections, with a focus on advancing enzymatic debridement approaches. The award period runs from...
- The University of Louisville was awarded a $696,371 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on "A DIRECT RAS PAN-INHIBITOR AS A NOVEL STRATEGY FOR LUMINAL B BREAST CANCER" from January 15, 2023 through January 14, 2026. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $763,171 to Louisiana State University (LSU) to conduct a pilot clinical trial of an app-based motor skills intervention for reducing motor difficulties in autistic children. The award period runs from July 1, 2025 to June 30, 2028. LSU has subcontracted with Pennington Biomedical Research Center to adapt and beta test the intervention app for diverse autistic...
- This $779,401 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support lung cancer research led by Tulane University. The 3-year grant, effective July 1, 2024, will fund the Lung Cancer Research Program Idea Development Award, which aims to advance innovative scientific studies around lung cancer prevention, diagnosis, and treatment. As a prime grantee, Tulane University will conduct research and...
- The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- This $1,872,750.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by The University of Texas Health Science Center at San Antonio (UTHSCSA) to develop the anti-prostate cancer agent Selisistat for the treatment of prostate cancer. The award, which runs from June 1, 2025 to May 31, 2028, will fund UTHSCSA's research to transform healthcare for military service members, veterans, and the...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,848,000.00 in funding to the Regents of the University of Minnesota, Office of Sponsored Projects Administration, to conduct research on "Therapeutic Targeting of Aberrant mRNA Polyadenylation in Lethal Prostate Cancer." The research, taking place in Minneapolis, MN, aims to advance scientific understanding and develop potential clinical applications...